MOXAZYD 25MG - CAP 14 MONONITRATO DE ISOSORBIDA PRINCIPIO ACTIVO: SOLIFENACINA SUCCINATO

Description

PRINCIPIO ACTIVO: SOLIFENACINA SUCCINATO

TYMBRO® 200 mg/mL (20%) | Solución para Infusión | Frasco 100 mL | Takeda

un anticuerpo monoclonal humano dirigido contra el antígeno CD20 de los linfocitos B

00 S/G MENTOL 1

MOXAZYD 25MG - CAP 14 MONONITRATO DE ISOSORBIDA PRINCIPIO ACTIVO: SOLIFENACINA SUCCINATO

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy